Cell culture refers to growth of cells in an artificially created, controlled environment, which is used to study the metabolism pathways in molecular and cellular biology. Various types of cell cultures include two-dimensional (2D) and three-dimensional (3D). 2D cell culture has multiple disadvantages such as they can neither provide adequate extracellular components nor appropriate in vivo environment. Moreover, there is lack of cell-cell and cell-matrix interactions, which are essential to study the functions, proliferation, and differentiation of a cell. 3D cell culture is an artificially created environment that facilitates interactions of cells with their surroundings in all three dimensions.
3D cell culture is a rapidly evolving technique in the field of research and technology. They are used to precisely observe and analyze the aspects of a cell such as morphology, differentiation, migration, and proliferation. These interactions assist to study the etiology of a disease, which boosts the growth of the market. In addition, 3D cultures can be used to reconstruct the physiology and anatomy of tissues. Moreover, they can be used to reconstruct in vivo-like conditions in a laboratory to conduct research on drug development and diseased models.
The global 3D cell culture market is estimated to reach $4,691 million by 2022 from $765 million in 2015, registering a CAGR of 29.4% from 2016 to 2022. The market growth is driven by rapidly expanding customer base, proactive government initiatives for the development of 3D cell cultures, and extensive R&D activities. The 3D cell culture technique has revolutionized various sectors such as tissue engineering and drug discovery for cancer, which further boosts the growth of the market. Moreover, collaborations between academic institutions, hospitals, and companies; rise in investments by major players; and high demand for organ transplantation have supplemented the market growth. However, high investments requirements and dearth of experienced & skilled professionals are the key factors that restrain the market growth.
The report segments the 3D cell culture market based on product type, application, end user, and geography. On the basis of product type, the market is categorized into scaffolds, scaffold-free platforms, gels, bioreactors, and microchips. Scaffold-based platforms are further classified into macro-porous, micro-porous, nano-porous, and solid scaffolds. Applications covered in the study include cancer research, stem cell research, drug discovery, and regenerative medicine. By end user, the market comprises biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, Republic of South Africa, and rest of LAMEA).
KEY BENEFITS
This report entails a detailed quantitative analysis of the current market trends for the period of 2014-2022 to identify the prevailing opportunities in the market.
The market estimations provided in the report are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product type, application, end user, and geography to assist in strategic business planning.
Recent developments and strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
The key market players in the 3D cell culture market are profiled in this report along their growth strategies to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product Type
Scaffold-Based Platforms
Macro-Porous Scaffolds
Micro-Porous Scaffolds
Nano-Porous Scaffolds
Solid Scaffolds
Scaffold-Free Platforms
Gels
Bioreactors
Microchips
Services
By Application
Cancer Research
Stem Cell Research
Drug Discovery
Regenerative Medicine
By End User
Biotechnology & Pharmaceutical Companies
Contract Research Laboratories
Academic Institutes
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
Republic of South Africa
Rest of LAMEA
The key players profiled in this report include
3D Biotek, LLC
Advanced Biomatrix, Inc.
Becton, Dickinson and Company
Corning Incorporated
Kuraray Co., Ltd.
Lonza Group Ltd.
Merck & Co., Inc.
Synthecon, Incorporated
Thermo Fisher Scientific Inc.
VWR Corporation
Other players of the 3D cell culture market include (companies not profiled in the report):
Global Cell Solutions, Inc.
InSphero AG
Nanofiber Solutions
Tecan Trading AG
